Literature DB >> 30856591

Provider perceptions of system-level opioid prescribing and addiction treatment policies.

Rebecca L Haffajee1, Cecelia A French2.   

Abstract

Stakeholders have implemented a multitude of system-level policies to address the U.S. opioid overdose epidemic. Because opioid prescribing partly fueled the crisis and because prescribing of medications for opioid addiction treatment is a key prevention strategy, it is critical to understand prescriber perceptions of policies in these domains. This article reviews prescriber awareness and opinions of the following system-level policies: opioid prescribing guidelines, prescription drug monitoring programs (PDMPs), medications for addiction treatment, and naloxone distribution programs. Most providers are aware of these policies, especially PDMPs, albeit a smaller proportion actively participate in their implementation. Low engagement in certain system-level policies is concerning and deserves attention, given that prescribers play an integral role in achieving optimal impact and mitigating the crisis.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30856591      PMCID: PMC7482312          DOI: 10.1016/j.copsyc.2019.01.018

Source DB:  PubMed          Journal:  Curr Opin Psychol        ISSN: 2352-250X


  60 in total

1.  A Survey of Prescribers' Attitudes, Knowledge, Comfort, and Fear of Consequences Related to an Opioid Overdose Education and Naloxone Distribution Program.

Authors:  Alyssa M Peckham; Maria E Niculete; Howard Steinberg; Douglas L Boggs
Journal:  J Public Health Manag Pract       Date:  2018 Jul/Aug

2.  Impact of prescription drug-monitoring program on controlled substance prescribing in the ED.

Authors:  Matthew W McAllister; Patrick Aaronson; Joe Spillane; Mark Schreiber; Genelyn Baroso; Dale Kraemer; Carmen Smotherman; Kelly Gray-Eurom
Journal:  Am J Emerg Med       Date:  2015-03-18       Impact factor: 2.469

3.  Mandatory use of prescription drug monitoring programs.

Authors:  Rebecca L Haffajee; Anupam B Jena; Scott G Weiner
Journal:  JAMA       Date:  2015-03-03       Impact factor: 56.272

4.  Primary Care Physicians' Knowledge and Attitudes Regarding Prescription Opioid Abuse and Diversion.

Authors:  Catherine S Hwang; Lydia W Turner; Stefan P Kruszewski; Andrew Kolodny; G Caleb Alexander
Journal:  Clin J Pain       Date:  2016-04       Impact factor: 3.442

5.  Changes in opioid prescribing for chronic pain in Washington State.

Authors:  Gary M Franklin; Deborah Fulton-Kehoe; Judith A Turner; Mark D Sullivan; Thomas M Wickizer
Journal:  J Am Board Fam Med       Date:  2013 Jul-Aug       Impact factor: 2.657

6.  Adherence to prescription opioid monitoring guidelines among residents and attending physicians in the primary care setting.

Authors:  Laila Khalid; Jane M Liebschutz; Ziming Xuan; Shernaz Dossabhoy; Yoona Kim; Denise Crooks; Christopher Shanahan; Allison Lange; Orlaith Heymann; Karen E Lasser
Journal:  Pain Med       Date:  2014-12-19       Impact factor: 3.750

7.  Exploratory study of emergency physicians' use of a prescription monitoring program using a framework of technology acceptance.

Authors:  Marc L Fleming; Mark D Hatfield; Monica K Wattana; Knox H Todd
Journal:  J Pain Palliat Care Pharmacother       Date:  2014-02-12

8.  Barriers to guideline-concordant opioid management in primary care--a qualitative study.

Authors:  Erin E Krebs; Alicia A Bergman; Jessica M Coffing; Steffanie R Campbell; Richard M Frankel; Marianne S Matthias
Journal:  J Pain       Date:  2014-08-29       Impact factor: 5.820

9.  Buprenorphine Maintenance Treatment of Opiate Dependence: Correlations Between Prescriber Beliefs and Practices.

Authors:  Kai MacDonald; Kristy Lamb; Michael L Thomas; Wendy Khentigan
Journal:  Subst Use Misuse       Date:  2016-01-15       Impact factor: 2.164

10.  Implementing buprenorphine in addiction treatment: payer and provider perspectives in Ohio.

Authors:  Todd Molfenter; Carol Sherbeck; Mark Zehner; Andy Quanbeck; Dennis McCarty; Jee-Seon Kim; Sandy Starr
Journal:  Subst Abuse Treat Prev Policy       Date:  2015-03-28
View more
  5 in total

1.  The Public Health Value of Opioid Litigation.

Authors:  Rebecca L Haffajee
Journal:  J Law Med Ethics       Date:  2020-06       Impact factor: 1.718

2.  Modifying and Evaluating the Opioid Overdose Knowledge Scale for Prescription Opioids: A Pilot Study of the Rx-OOKS.

Authors:  Jo Ann Shoup; Shane R Mueller; Ingrid A Binswanger; Anna V Williams; John Strang; Jason M Glanz
Journal:  Pain Med       Date:  2020-10-01       Impact factor: 3.750

Review 3.  The Association of State Opioid Misuse Prevention Policies With Patient- and Provider-Related Outcomes: A Scoping Review.

Authors:  Amanda I Mauri; Tarlise N Townsend; Rebecca L Haffajee
Journal:  Milbank Q       Date:  2019-12-04       Impact factor: 4.911

4.  Prescription Drug Monitoring Programs - Friend or Folly in Addressing the Opioid-Overdose Crisis?

Authors:  Rebecca L Haffajee
Journal:  N Engl J Med       Date:  2019-08-22       Impact factor: 91.245

Review 5.  A Critical Review of the Social and Behavioral Contributions to the Overdose Epidemic.

Authors:  Magdalena Cerdá; Noa Krawczyk; Leah Hamilton; Kara E Rudolph; Samuel R Friedman; Katherine M Keyes
Journal:  Annu Rev Public Health       Date:  2021-11-30       Impact factor: 21.981

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.